NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 289 filers reported holding NEOGENOMICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $150,000 | -98.1% | 12,376 | -94.5% | 0.00% | -98.0% |
| Q4 2021 | $7,735,000 | -32.4% | 226,704 | -4.5% | 0.20% | -35.2% |
| Q3 2021 | $11,448,000 | +7.1% | 237,323 | +0.3% | 0.31% | +2.7% |
| Q2 2021 | $10,687,000 | -5.7% | 236,591 | +0.7% | 0.30% | -12.6% |
| Q1 2021 | $11,328,000 | -23.0% | 234,868 | -14.0% | 0.34% | -22.3% |
| Q4 2020 | $14,704,000 | +45.0% | 273,100 | -0.6% | 0.44% | +18.0% |
| Q3 2020 | $10,139,000 | +21.6% | 274,835 | +2.1% | 0.37% | +21.5% |
| Q2 2020 | $8,340,000 | +670.1% | 269,205 | +586.1% | 0.31% | +479.2% |
| Q1 2020 | $1,083,000 | -23.8% | 39,239 | -19.2% | 0.05% | -11.7% |
| Q4 2019 | $1,421,000 | +53.0% | 48,570 | 0.0% | 0.06% | +46.3% |
| Q3 2019 | $929,000 | -12.9% | 48,570 | -0.0% | 0.04% | -10.9% |
| Q2 2019 | $1,066,000 | +3.5% | 48,590 | -3.4% | 0.05% | -4.2% |
| Q1 2019 | $1,030,000 | +108.1% | 50,325 | +28.2% | 0.05% | +84.6% |
| Q4 2018 | $495,000 | – | 39,250 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |